Gout Medication for the Elderly: A Caregiver's Guide to Treatment and Safety

Gout is one of the most painful conditions an older adult can experience, and it is far more common in seniors than most people realize. In the United States, gout affects nearly 10% of men over 65, and rates increase with age. For caregivers managing an elderly parent's medications, gout treatment adds a layer of complexity: the standard drugs used to treat gout carry specific risks and interactions in older adults that younger patients don't face in the same way.

This guide covers the main categories of gout medication, what makes each one complicated for elderly patients specifically, and how to work with the care team to keep your parent safe during both flares and long-term management.

Understanding Gout Briefly

Gout results from elevated uric acid in the blood (hyperuricemia). When uric acid crystallizes and deposits in a joint — most commonly the big toe, ankle, or knee — it triggers an intensely inflammatory response. The pain is often described as the worst joint pain imaginable.

Treatment falls into two categories:

1. Acute flare treatment — stopping the pain and inflammation of an active attack
2. Long-term urate-lowering therapy (ULT) — reducing blood uric acid levels to prevent future attacks and joint damage

The drugs used for each category carry different risk profiles for older adults.

Acute Flare Medications: What's Prescribed and What to Watch For

NSAIDs (Ibuprofen, Naproxen, Indomethacin)

Non-steroidal anti-inflammatory drugs are a first-line treatment for acute gout flares in the general adult population because they work quickly and effectively. For elderly patients, they are a significant concern.

The American Geriatrics Society Beers Criteria explicitly recommends against regular NSAID use in older adults. The reasons are compounded in gout patients:

• Kidney risk. NSAIDs reduce blood flow to the kidneys. Many elderly patients already have reduced kidney function, and elevated uric acid itself indicates the kidneys are not filtering efficiently. NSAIDs on top of impaired kidneys can cause acute kidney injury.
• GI bleeding. The risk of serious gastrointestinal bleeding from NSAIDs is significantly elevated in older adults. In a patient taking a blood thinner (anticoagulant) — which is common in elderly patients with atrial fibrillation or a history of clots — adding even short-term NSAID use for a gout flare can double the bleeding risk. This combination requires explicit physician guidance.
• Blood pressure and heart failure worsening. NSAIDs cause fluid retention and can raise blood pressure, worsen heart failure, and reduce the effectiveness of blood pressure medications.
• Specific concern with indomethacin. Indomethacin is one of the most potent oral NSAIDs and has historically been a first choice for gout flares. In elderly patients, it has a disproportionately high risk of GI bleeding, kidney injury, and central nervous system effects (confusion, dizziness). Most geriatric guidelines now recommend against indomethacin specifically in older adults.

What you should know as a caregiver: If the doctor prescribes an NSAID for a gout flare, it is reasonable to ask: "Given that Mom is on [blood thinner / kidney disease / heart failure medication], is there a safer alternative for this flare?" The answer may be colchicine or a short course of prednisone.

Colchicine

Colchicine is often the preferred acute gout treatment for older adults when NSAIDs are not safe. It works by a different mechanism — reducing neutrophil-mediated inflammation — and does not carry the kidney or bleeding risks of NSAIDs.

That said, colchicine in elderly patients has its own considerations:

• Dose reduction is often required. Because colchicine is processed by the kidneys and liver, impaired function in either organ increases the drug's concentration in the body. Older adults should generally receive lower doses than the standard adult dose.
• Drug interactions. Colchicine has several significant interactions:
  • Statins (atorvastatin/Lipitor, simvastatin/Zocor, rosuvastatin/Crestor). The combination of colchicine and statins increases the risk of muscle damage (myopathy and rhabdomyolysis). This is a serious interaction that requires monitoring, especially if the dose of either drug is being increased.
  • Clarithromycin and other macrolide antibiotics. This antibiotic dramatically increases colchicine levels in the blood, which can cause toxicity. Colchicine toxicity is dangerous — it causes diarrhea, nausea, and can progress to bone marrow suppression. If your parent is prescribed clarithromycin while on maintenance colchicine, the prescribing doctor needs to know about the colchicine.
  • Some antifungals (fluconazole, itraconazole). Similar interaction mechanism; increases colchicine exposure.
  • Cyclosporine. A combination that should generally be avoided.

What you should know as a caregiver: Colchicine interactions are not always caught automatically because statins are often managed by one doctor and gout medications by another. Your Master Medication Record is what prevents this from falling through the cracks. When a new antibiotic is prescribed, specifically tell the prescriber: "She is on colchicine — are there any interactions I should know about?"

Corticosteroids (Prednisone, Methylprednisolone)

Oral or injected corticosteroids are a third option for acute flares, often used when NSAIDs and colchicine are both problematic. They work quickly and do not carry kidney or direct bleeding risks.

For elderly patients, the concerns with steroids center on:

• Blood sugar elevation. Even a short course of prednisone can cause significant spikes in blood glucose. If your parent has diabetes or is borderline diabetic, this requires closer monitoring during the course.
• Blood pressure increase. Steroids cause fluid retention, which can worsen hypertension or heart failure.
• Immunosuppression. Short courses at standard doses are generally manageable, but elderly patients are more vulnerable to infections during a course of steroids.
• Bone density. Repeated or prolonged courses accelerate bone loss, which is already a concern for older adults.

For a short-course of 5–7 days for a flare, these risks are typically manageable and outweigh the alternative of an undertreated, agonizing flare. The key is flagging the blood sugar and blood pressure implications to the doctor so monitoring is in place.

Long-Term Urate-Lowering Therapy (ULT)

If your parent has frequent gout attacks (two or more per year), has gouty tophi (urate crystal deposits under the skin), or has joint damage from gout, the doctor will likely recommend long-term medication to lower uric acid levels and prevent future attacks.

Allopurinol

Allopurinol is the first-line long-term gout medication for most patients, including elderly adults. It reduces uric acid production. When properly dosed for kidney function, allopurinol has a good safety profile in older adults.

Several caregiver-relevant points:

• Kidney function determines dosing. Because elderly patients typically have reduced kidney function, the dose of allopurinol must be calibrated to the creatinine clearance (eGFR) — a lab value that should be checked before starting and periodically thereafter. Starting at a lower dose and titrating slowly is standard practice in older adults.
• Do not stop during a flare. A common mistake is stopping allopurinol when a gout attack begins because patients think it is making things worse. Stopping and restarting allopurinol actually triggers flares. It should be continued through an attack.
• Allopurinol hypersensitivity syndrome. A rare but serious reaction that is more common in patients with reduced kidney function. Symptoms include a severe skin rash, fever, and organ involvement. Call the doctor immediately if your parent develops a rash after starting allopurinol.
• Interaction with azathioprine (Imuran) and 6-mercaptopurine. These immunosuppressants are inactivated by the same enzyme that allopurinol inhibits. The combination can cause dangerously elevated levels of these drugs, with serious toxicity. If your parent takes either of these drugs, allopurinol is generally avoided.

Febuxostat (Uloric)

Febuxostat works similarly to allopurinol but through a different mechanism. It is sometimes used when allopurinol is not tolerated.

A clinically significant concern: a 2018 FDA-mandated safety trial found that febuxostat was associated with higher rates of cardiovascular death compared to allopurinol in patients with existing cardiovascular disease. The FDA subsequently added a black-box warning. For elderly patients, who frequently have cardiovascular disease, this is a meaningful consideration. The prescribing doctor should be aware of your parent's cardiac history when febuxostat is on the table.

Probenecid

Probenecid works differently from allopurinol — it increases uric acid excretion through the kidney rather than reducing production. It is generally less commonly used as a first-line agent and is contraindicated in patients with significant kidney disease (which is common in older adults) or a history of kidney stones.

The Intersection of Diuretics and Gout

One factor that makes gout management complicated in elderly patients is that many seniors are on diuretics — water pills like furosemide (Lasix), hydrochlorothiazide (HCTZ), or chlorthalidone — for heart failure, high blood pressure, or edema.

Thiazide diuretics (HCTZ, chlorthalidone) and loop diuretics (furosemide) both raise uric acid levels by reducing the kidney's excretion of urate. This is a recognized side effect and a significant driver of gout in elderly patients who may never have had gout until they started a diuretic.

If your parent's gout seems to have appeared or worsened after a diuretic was added, that connection is worth raising with the prescribing doctor. Sometimes a medication adjustment is possible; other times the diuretic is medically necessary and the answer is managing the gout separately.

Tracking Gout Medications in the Context of a Complex Regimen

Elderly patients with gout are rarely managing just gout. They are typically also managing hypertension, possibly atrial fibrillation (and therefore anticoagulants), often diabetes, and often cardiovascular disease. Each of these conditions and their medications intersects with gout treatment:

Managing this complexity effectively requires a complete, up-to-date medication record that goes to every provider. The typical elderly patient with gout is seeing at least a primary care doctor, possibly a rheumatologist or nephrologist, and filling prescriptions at a pharmacy — and none of these parties automatically see the full picture.

What Caregivers Can Do

Keep a complete medication list. Every prescription, every supplement (fish oil, herbal products), every OTC drug goes on this list. Gout medication interactions often involve supplements and OTCs, not just other prescriptions.

Consolidate to one pharmacy. When all prescriptions are at one pharmacy, the pharmacist's Drug Utilization Review runs against the complete profile. The colchicine-statin interaction, for example, is something a pharmacist will flag if both are in the same system.

Know the flare plan in advance. Don't wait for a painful 3 AM gout attack to figure out what to do. Ask the doctor ahead of time: "If she has a flare, what's the treatment plan given her other medications?" Having that answer documented prevents the emergency room from reaching for indomethacin without knowing about her anticoagulant.

Monitor kidney function. Because kidney function determines safe dosing for both allopurinol and colchicine, and because gout itself can damage the kidneys over time, creatinine and eGFR should be checked at least annually and after any dose changes to these medications.

Coordinating all of this across multiple providers is the core challenge of managing gout in an elderly parent. Having a structured system for medication tracking, doctor appointment preparation, and provider communication makes the difference between reactive crisis management and proactive safety.

The Medication Management Kit for Caregivers includes a Master Medication Record, a Medication Interaction Tracker worksheet, and a Doctor Appointment Prep Sheet with specific language for raising concerns about drug interactions and requesting medication reviews. It is built for exactly the situation that gout in a complex elderly patient creates.

Get the Medication Management Kit